bioAffinity Technologies, Inc.
Support and Resistance Levels
Past performance
News About BIAF
All events for BIAF
All deals for BIAF
Financial Ratios
Financial Statements
BIAF vs Sector & Peers
About bioAffinity Technologies, Inc.
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014. Website bioaffinitytech.com
Headquarters San Antonio, TX, US